Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Yanik

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 10, 2015
Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)Margaret J Zhou, Michelle Y Doral, Steven G DuBois, et al.
Clinical Pulmonary Medicine|March 27, 2019
Respiratory Tract Colonization by <i>Candida</i> species Portends Worse Outcomes in Immunocompromised PatientsKathryn M Pendleton, Robert P Dickson, Duane W Newton, et al.
Pediatric Blood & Cancer|February 18, 2011
Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology GroupArlene Naranjo, Marguerite T Parisi, Barry L Shulkin, et al.
Pediatric Blood & Cancer|April 10, 2007
Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1HMwe Mwe Chao, John E Levine, James L Ferrara, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastomaKenneth F Koral, John P Huberty, Bill Frame, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lungSameem Abedin, Gregory A Yanik, Thomas Braun, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 2011
Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantationGregory A Yanik, Shin Mineishi, John E Levine, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 2, 2014
Transforming growth factor-β induces microRNA-29b to promote murine alveolar macrophage dysfunction after bone marrow transplantationRacquel Domingo-Gonzalez, Carol A Wilke, Steven K Huang, et al.
American Journal of Respiratory and Critical Care Medicine|September 30, 2015
Inhibition of Neutrophil Extracellular Trap Formation after Stem Cell Transplant by Prostaglandin E2Racquel Domingo-Gonzalez, Giovanny J Martínez-Colón, Alana J Smith, et al.
Pediatric Blood & Cancer|January 3, 2026
Parent-to-Child Information Disclosure in Pediatric OncologyRachel A Kentor, Flora Hoodin, Michelle Byrd, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|August 10, 2015
Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)Margaret J Zhou, Michelle Y Doral, Steven G DuBois, et al.
Clinical Pulmonary Medicine|March 27, 2019
Respiratory Tract Colonization by <i>Candida</i> species Portends Worse Outcomes in Immunocompromised PatientsKathryn M Pendleton, Robert P Dickson, Duane W Newton, et al.
Pediatric Blood & Cancer|February 18, 2011
Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology GroupArlene Naranjo, Marguerite T Parisi, Barry L Shulkin, et al.
Pediatric Blood & Cancer|April 10, 2007
Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1HMwe Mwe Chao, John E Levine, James L Ferrara, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastomaKenneth F Koral, John P Huberty, Bill Frame, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lungSameem Abedin, Gregory A Yanik, Thomas Braun, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 2011
Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantationGregory A Yanik, Shin Mineishi, John E Levine, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 2, 2014
Transforming growth factor-β induces microRNA-29b to promote murine alveolar macrophage dysfunction after bone marrow transplantationRacquel Domingo-Gonzalez, Carol A Wilke, Steven K Huang, et al.
American Journal of Respiratory and Critical Care Medicine|September 30, 2015
Inhibition of Neutrophil Extracellular Trap Formation after Stem Cell Transplant by Prostaglandin E2Racquel Domingo-Gonzalez, Giovanny J Martínez-Colón, Alana J Smith, et al.
Pediatric Blood & Cancer|January 3, 2026
Parent-to-Child Information Disclosure in Pediatric OncologyRachel A Kentor, Flora Hoodin, Michelle Byrd, et al.
Pageof 8